With deep expertise in biopharmaceutical research and development, Ivan Kairatov has a front-row seat to the breakthroughs and setbacks that define modern medicine. He joins us to dissect the recent turbulence in the multiple sclerosis (MS) treatment landscape, where a promising new class of drugs
For the millions of people living with the relentless progression of Parkinson's disease, the daily battle for motor control has long been fought with a limited and often burdensome arsenal of treatments. The landscape of this fight is on the cusp of a dramatic transformation, however, as two
A recent international study is fundamentally changing the way clinicians understand and diagnose hereditary colorectal cancer, revealing that a direct analysis of colorectal polyp DNA can uncover critical information that standard blood tests frequently overlook. This groundbreaking research, a
A comprehensive and detailed analysis from a recent study is reshaping the landscape of precision oncology, revealing the significant potential of whole-genome sequencing (WGS) to revolutionize how patient responses to PARP inhibitor cancer treatments are predicted. The findings, published in the
The very genetic chaos that has long fueled a tumor's relentless growth may now be the most precise roadmap to its destruction. A groundbreaking clinical trial has provided definitive evidence that cancer treatment can be radically personalized, shifting the field of oncology away from generalized
A sweeping nationwide study from Sweden has delivered a definitive answer to one of public health’s most critical questions, demonstrating that high-coverage vaccination programs against the human papillomavirus (HPV) create a powerful shield of protection that extends even to those who have not
